UBS Group’s ESSA Pharma EPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,473
Closed -$1.05K 10672
2025
Q3
$1.05K Sell
5,473
-6,548
-54% -$7.84K ﹤0.01% 9448
2025
Q2
$20.4K Sell
12,021
-11,587
-49% -$19.5K ﹤0.01% 8420
2025
Q1
$37.3K Sell
23,608
-72,006
-75% -$122K ﹤0.01% 7798
2024
Q4
$171K Buy
95,614
+93,197
+3,856% +$297K ﹤0.01% 6553
2024
Q3
$14.6K Buy
2,417
+852
+54% +$4.68K ﹤0.01% 7536
2024
Q2
$8.23K Sell
1,565
-2,061
-57% -$13.1K ﹤0.01% 7810
2024
Q1
$30.8K Sell
3,626
-1,269
-26% -$11.1K ﹤0.01% 6725
2023
Q4
$32.3K Buy
4,895
+4,730
+2,867% +$23.3K ﹤0.01% 6806
2023
Q3
$510 Sell
165
-265
-62% -$764 ﹤0.01% 8451
2023
Q2
$1.16K Sell
430
-2,824
-87% -$8.28K ﹤0.01% 7998
2023
Q1
$9.66K Sell
3,254
-3,268
-50% -$9.6K ﹤0.01% 7635
2022
Q4
$16.4K Buy
+6,522
New +$18.7K ﹤0.01% 7905
2022
Q3
Sell
-28,551
Closed -$90K 10480
2022
Q2
$90K Sell
28,551
-2,891
-9% -$16.2K ﹤0.01% 5508
2022
Q1
$194K Buy
31,442
+329
+1% +$2.89K ﹤0.01% 5394
2021
Q4
$442K Buy
31,113
+16,227
+109% +$181K ﹤0.01% 5077
2021
Q3
$119K Sell
14,886
-43,154
-74% -$686K ﹤0.01% 5702
2021
Q2
$1.66M Buy
58,040
+57,172
+6,587% +$1.66M ﹤0.01% 3743
2021
Q1
$25K Buy
868
+464
+115% +$10.8K ﹤0.01% 7166
2020
Q4
$5K Sell
404
-2,347
-85% -$16.5K ﹤0.01% 7825
2020
Q3
$19K Buy
+2,751
New +$18.7K ﹤0.01% 6343
2020
Q2
Sell
-1,625
Closed -$7K 8031
2020
Q1
$7K Buy
1,625
+913
+128% +$4.59K ﹤0.01% 7135
2019
Q4
$4K Buy
+712
New +$3.31K ﹤0.01% 7654
2018
Q2
Sell
-1,590
Closed -$6K 8051
2018
Q1
$6K Buy
1,590
+1,177
+285% +$4.9K ﹤0.01% 7138
2017
Q4
$2K Buy
+413
New +$2.15K ﹤0.01% 7604
2017
Q3
Sell
-300
Closed -$3K 7785
2017
Q2
$3K Buy
+300
New +$9.8K ﹤0.01% 7286
2016
Q1
Sell
-52
Closed -$4K 7762
2015
Q4
$4K Buy
+52
New +$5.43K ﹤0.01% 7768